Walsh & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$428K Hold
1,615
– – 0.33% 36
2026
Q2
$410K Sell
1,615
-3
-0.2% -$699 0.34% 37
2026
Q1
$396K Buy
1,618
+3
+0.2% +$699 0.39% 37
2025
Q4
$334K Hold
1,615
– – 0.33% 39

Other funds holding JNJ

Walsh & Associates's JNJ Position: Q3 2026 in Review

Walsh & Associates held its Johnson & Johnson (JNJ) position steady in Q3 2026 at 1,615 shares worth $428K. The position accounts for 0.33% of the portfolio, ranked #36.

Walsh & Associates first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 4,737 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Walsh & Associates held 1,615 shares of Johnson & Johnson worth $428K as of Q3 2026.
  • Walsh & Associates left its Johnson & Johnson share count unchanged in Q3 2026.
  • Johnson & Johnson made up 0.33% of Walsh & Associates's portfolio in Q3 2026, its #36 holding.
  • Walsh & Associates first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • 4,737 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.